Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

65.91
+0.41000.63%
Post-market: 65.69-0.2200-0.33%18:24 EST
Volume:361.76K
Turnover:23.79M
Market Cap:2.80B
PE:-33.08
High:66.62
Open:65.40
Low:64.59
Close:65.50
52wk High:85.25
52wk Low:38.51
Shares:42.45M
Float Shares:30.35M
Volume Ratio:0.55
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9925
EPS(LYR):-3.0729
ROE:-28.35%
ROA:-12.00%
PB:8.35
PE(LYR):-21.45

Loading ...

Tarsus Pharmaceuticals price target raised to $68 from $51 at Goldman Sachs

TIPRANKS
·
Feb 05

Does Tarsus Pharmaceuticals (NASDAQ:TARS) Have A Healthy Balance Sheet?

Simply Wall St.
·
Jan 15

Tarsus Pharmaceuticals Chief Human Resources Officer Dianne C. Whitfield Reports Disposal of Common Shares

Reuters
·
Jan 07

Tarsus Pharmaceuticals CEO Bobak Azamian Reports Disposal of Common Shares

Reuters
·
Dec 31, 2025

Tarsus Pharmaceuticals Chief Human Resources Officer Dianne C. Whitfield Reports Disposal of Common Shares

Reuters
·
Dec 19, 2025

Tarsus Pharmaceuticals Director William J. Link Reports Sale of Common Shares

Reuters
·
Dec 18, 2025

Tarsus Pharmaceuticals Initiated at Overweight by Barclays

Dow Jones
·
Dec 10, 2025

Tarsus Pharmaceuticals to Join BTIG Annual Ophthalmology Investor Conference

Reuters
·
Nov 25, 2025

Tarsus Pharmaceuticals Initiated at Outperform by Mizuho

Dow Jones
·
Nov 21, 2025

Mizuho Initiates Tarsus Pharmaceuticals at Outperform With $100 Price Target

MT Newswires Live
·
Nov 20, 2025

Tarsus Pharmaceuticals Inc : Mizuho Initiates Coverage With Outperform Rating; Target Price $100

THOMSON REUTERS
·
Nov 20, 2025

Tarsus Pharmaceuticals initiated with an Outperform at Mizuho

TIPRANKS
·
Nov 20, 2025

Why Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising Revenue Guidance and Narrowing Losses

Simply Wall St.
·
Nov 14, 2025

Tarsus to Participate in Upcoming Investor Conference

GlobeNewswire
·
Nov 06, 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Nov 06, 2025

Tarsus Pharmaceuticals Is Maintained at Buy by Guggenheim

Dow Jones
·
Nov 05, 2025

Tarsus Pharmaceuticals Q3 EPS $(0.30) Beats $(0.38) Estimate, Sales $118.697M Beat $115.222M Estimate

Benzinga
·
Nov 05, 2025

Tarsus Pharmaceuticals Q3 EPS USD -0.3

THOMSON REUTERS
·
Nov 05, 2025

Press Release: Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements

Dow Jones
·
Nov 05, 2025

Tarsus Pharmaceuticals Inc expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
Nov 01, 2025